KYBELLA™ (deoxycholic acid) injection is indicated for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults.
— Pate, Danielle, June 11, 2019
by Ramtin Kassir, M.D., F.A.C.S. | Learn More About Dr. Kassir >
KYBELLA™ is the first and only FDA-approved injectable drug that contours and improves the appearance of submental fullness. KYBELLA™ allows you to further expand your aesthetic injectable portfolio and offerings to your patients.
Treatment with KYBELLA™ is customized by the physician to the patient’s aesthetic goals for an improved chin profile. Once the aesthetic response is achieved with KYBELLA™, re-treatment is not expected.
As seen on